Table 4.
Third-generation bronchi | Fourth-generation bronchi | Fifth-generation bronchi | Sixth-generation bronchi | |||||
---|---|---|---|---|---|---|---|---|
ρ | p-value | ρ | p-value | ρ | p-value | ρ | p-value | |
Age | 0.566 | <0.001 | 0.533 | <0.001 | 0.562 | <0.001 | 0.556 | <0.001 |
Duration of asthma | 0.057 | 0.725 | 0.182 | 0.260 | −0.112 | 0.496 | −0.149 | 0.367 |
Blood %eosinophil | 0.005 | 0.977 | 0.169 | 0.311 | 0.071 | 0.675 | 0.146 | 0.390 |
Blood total IgE | −0.197 | 0.250 | −0.204 | 0.233 | −0.066 | 0.705 | −0.177 | 0.310 |
FEV1, % predicted | 0.056 | 0.734 | 0.099 | 0.544 | 0.202 | 0.217 | 0.174 | 0.289 |
FEV1/FVC ratio | −0.156 | 0.336 | −0.219 | 0.174 | −0.198 | 0.226 | −0.192 | 0.240 |
MMF, % predicted | −0.089 | 0.585 | −0.086 | 0.597 | −0.073 | 0.659 | −0.060 | 0.715 |
Inhaled corticosteroid dose | −0.141 | 0.400 | −0.014 | 0.933 | −0.184 | 0.268 | −0.269 | 0.102 |
Data are expressed as Spearman rank correlation coefficient (ρ) and p-value. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; MMF, maximum mid-expiratory flow rate.